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Skin cancer, the most prevalent form of cancer in Cauca-
sians, is mostly caused by exposure to the ultraviolet (UV)
wavelengths found in sunlight. UV radiation that reaches the
surface of the earth from the sun is divided into two wave-
bands, UVB (290–320 nm) and UVA (320–400 nm), with
visible light being made up of longer wavelengths. The
composition of sunlight varies with latitude and time of the
day, but usually is made up of about 20 times more UVA
than UVB. It is critical that humans protect themselves from
the damaging effects of UV radiation. Sunlight avoidance is
often not practical or not observed because of work con-
straints or recreational activities, and therefore other means
of protection from sunlight are required. Sunscreens con-
taining UV filters are a valuable protective measure. Under-
standing the molecular mechanisms of photodamage that
lead to skin cancer will enable the development of biological
interventions that prevent these molecular mechanisms.
This is likely to provide an additional powerful means of
photoprotection.
In this issue of the journal, Decraene et al (2005) suggest
a new possibility for photoprotection: activation of molec-
ular photoadaption to sunlight. It is well recognized that the
skin adapts to sunlight in order to reduce damage from
subsequent exposures. Adaptive processes include mela-
nin production and increased epidermal thickening, both of
which attenuate the amount of UV radiation that reaches the
basal cells of the epidermis. Decraene and colleagues have
investigated adaptation at the molecular level, as they be-
lieve that it may be possible to activate molecular skin
mechanisms through a non-damaging agent other than UV
radiation does not cause damage to the skin. This would
provide an additional level of photoprotection to conven-
tional sunscreens or biological interventions that reverse
damage after it has occurred. It would condition the skin
into a state where UV damage is less extensive. They found
that exposure to low-dose broadband UVB provided by TL
20W12 fluorescent tubes reduced apoptosis caused by a
higher dose of UVB 24 h later. The mechanism of this pho-
toadaption involved upregulation of p21/WAF1 and p53R2.
These genes are both activated by p53, and are involved in
cell cycle arrest and DNA repair, respectively. The low dose
of photoadaptive UVB also increased and stabilized p53, as
demonstrated by an increase in p53 phosphorylated at se-
rine 15. The authors therefore propose that low-dose UVB
upregulates and stabilizes p53, which induces cell cycle
arrest via p21/WAF1 induction and enhancement of DNA
repair via increases in p53R2. This increases the resistance
of keratinocytes to a subsequent exposure to photodam-
aging levels of UVB, as the cell is primed for DNA repair
rather than division when exposed to the higher damaging
UVB dose. Upregulated p21/WAF1 induces cell cycle ar-
rest, enabling the cells to undergo DNA repair, which is also
increased. These adaptive molecular mechanisms required
24 h following the low-dose exposure to allow for P53
activation. The low-dose UVB was only protective if suffi-
cient time was allowed for p53 to activate these protective
mechanisms. Therefore, this study shows that p53 helps the
skin adapt to UVB by initiating protective measures.
Both UVB and UVA cause photodamage that is likely to
be important for skin carcinogenesis. UVA, as well as UVB,
increases levels of immunoreactive p53 protein, but pre-
dominantly in the basal layer of the epidermis (Campbell
et al, 1993). Also, UVB and UVA in sunlight appear to make
approximately equal contributions towards the induction of
genetic mutations in p53 in human skin cancer. Similar
numbers of mutations attributable to these wavebands can
be found in p53 in human squamous cell carcinomas and
their benign precursors actinic keratosis (Agar et al, 2004).
Interestingly, UVA mutations are predominantly located at
the basal layer of skin tumors, the same region in which
UVA-increased levels of p53 are found. In contrast, UVB-
induced mutations are restricted to the upper layers of skin
tumors. Thus, UVA and UVB appear to primarily affect p53
at different depths within tumors. Whether this is because of
localization of UVA photoabsorbers or some other event is
unknown. This is, however, important as skin tumors are
thought to arise from transient amplifying or stem cells lo-
cated at the basal layer of the epidermis. In human epider-
mis, cells at the basal layer are less differentiated, but
capable of dividing compared with the terminally differen-
tiated cells at the surface of the skin. It is possible that p53
in basal and terminally differentiated keratinocytes may
respond differently to UVB and UVA. It would be interest-
ing to extend the studies of Decraene and colleagues to
determine whether UVA as well as UVB activates p53-me-
diated adaptive responses to sunlight, and whether suchAbbreviation: UV, ultraviolet
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adaptive responses are different in well-differentiated cells
at the surface of the skin compared with basal cells at the
base of the epidermis. Decraene and colleagues irradiated
cultured keratinocytes isolated from human foreskins that
would presumably have had little if any prior exposure to
sunlight, and therefore little chance of having developed an
adaptive response prior to the low-dose UVB exposure they
received in this study. Adult keratinocytes may behave dif-
ferently, particularly in their stratified differentiation state
within skin. In a recent study it has been shown that
high-dose UVA1 (340–400 nm) does not increase levels of
p53 stabilized by phosphorylation at serine 15, or of p21/
WAF1 (Beattie et al, 2005). It is therefore possible that UVA
would not cause the photoadaptive response reported in
this issue.
A number of studies have shown that the skin adapts to
chronic UV exposure by inducing a range of protective
mechanisms; melanin production is the best characterized
of these adaptive responses. UVB initiates production of
a melanocyte stimulating hormone (a-MSH) along with
other paracrine factors from cutaneous keratinocytes and
melanocytes, which leads to increased melanin production
(Gilchrest and Eller, 1999). Synthetic potent derivatives
of a-MSH are being developed to increase tanning in
humans without the need for sunlight exposure as an
approach to activating this photoadaptive response in order
to protect from sun damage (Dorr et al, 2000). Thymine
dimers, one of the forms of DNA damage caused by UV
exposure, are able to activate p53, increase DNA repair, and
induce melanization. Topical application of thymine dimers
is able to activate these protective measures (Gilchrest
and Eller, 1999; Goukassian et al, 2004). Thus, based on
understanding the molecular events involved in photo-
adaption, it should be possible to develop procedures that
convert cells into a state that makes them less susceptible
to photodamage.
In addition to UV-induced genetic mutations, UV-induced
immunosuppression is an important form of damage during
photocarcinogenesis. Immunosuppression also adapts to
UV exposure. Exposure of humans to both low-dose UVB
and UVA causes immunosuppression. Repeated exposures
24 h apart with UVA for 4 d, or UVB for 5 d are not
immunosuppressive, indicating that an adaptive mecha-
nism is activated that prevents immunosuppression from
subsequent exposures (Damian et al, 1999). Higher dose
UVA induces the production of interferon-g and the antioxi-
dant enzyme heme oxygenase-1 (HO-1), which protects
from UVB-induced immunosuppression. This adaptive re-
sponse occurs more rapidly than that described in this issue
by Decraene and colleagues, as it can prevent immuno-
suppression caused by UVB exposure delivered immedi-
ately following the UVA, and HO-1 is induced immediately
following high-dose UVA exposure (Allanson and Reeve,
2004). This adaptive response, increased HO-1, can also be
induced by curcumin, a spice commonly used in foods that
mediates this effect at least partially via the NF-kB tran-
scription pathway (Hill-Kapturczak et al, 2001).
Study of the mechanisms of photadaptation will enable
this process to be induced by biological modifiers other
than UV radiation, and this approach provides considerable
promise for improved photoprotection. It should be possible
to develop effective strategies for this purpose that do not
cause the damage that would be inflicted by UV-induced
adaptation. Epigallocatechin-3-gallate (EGCG) is a phenolic
compound of green tea, which is an effective chemopre-
ventative agent. Like the low-dose UVB protocol in the
study by Decraene and colleagues in this issue, EGCG up-
regulates and stabilizes p53, leading to an increase in p21/
WAF1 and cell cycle arrest (Hastak et al, 2005). Activation of
this p53-dependent pathway is likely to be at least partially
responsible for the protective effects of this compound. Ar-
tificial methods for adaptation of the skin so that it has re-
duced damage following exposure to sunlight, such as
synthetic derivatives of a-MSH to augment melanogenesis,
thymine dimers to increase DNA repair and melanogenesis,
curcumin to enhance HO-1 levels, or EGCG to activate p53-
dependent protective pathways, are all promising. A variety
of strategies, including sun avoidance, use of sunscreens
with UV filters, and biological modifiers that repair UV dam-
age or adapt the skin so that it is less sensitive to the dam-
aging effects of sunlight, may eventually help to reduce the
incidence of skin cancer.
DOI: 10.1111/j.0022-202X.2005.23940.x
References
Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM:
The basal layer in human squamous tumors harbors more UVA than UVB
fingerprint mutations: A role for UVA in human skin carcinogenesis. Proc
Natl Acad Sci USA 101:4954–4959, 2004
Allanson M, Reeve VE: Immunoprotective UVA (320–400 nm) irradiation upreg-
ulates heme oxygenase-1 in the dermis and epidermis of hairless mouse
skin. J Invest Dermatol 122:1030–1036, 2004
Beattie PE, Finlan LE, Kernohan NM, Thomson G, Hupp TR, Ibbotson SH: The
effect of ultraviolet (UV) A1, UVB and solar-simulated radiation on p53
activation and p21(Waf1/Cip1). Br J Dermatol 152:1001–1008, 2005
Campbell C, Quinn AG, Angus B, Farr PM, Rees JL: Wavelength specific patterns
of p53 induction in human skin following exposure to UV radiation. Can-
cer Res 53:2697–2699, 1993
Damian DL, Barnetson RS, Halliday GM: Low-dose UVA and UVB have different
time courses for suppression of contact hypersensitivity to a recall an-
tigen in humans. J Invest Dermatol 112:939–944, 1999
Decraene D, Smaers K, Maes D, Matsui M, Declercq L, Garmyn M: A low UVB
dose, with the potential to trigger a protective p53-dependent gene pro-
gram, increases the resilience of keratinocytes against future UVB-insults.
J Invest Dermatol 789–791, 2005
Dorr RT, Dvorakova K, Brooks C, et al: Increased eumelanin expression and
tanning is induced by a superpotent melanotropin Nle(4)-D-Phe(7)-alpha-
MSH in humans. Photochem Photobiol 72:526–532, 2000
Gilchrest BA, Eller MS: DNA photodamage stimulates melanogenesis and other
photoprotective responses. J Investig Dermatol Symp Proc 4:35–40,
1999
Goukassian DA, Helms E, van Steeg H, van Oostrom C, Bhawan J, Gilchrest BA:
Topical DNA oligonucleotide therapy reduces UV-induced mutations
and photocarcinogenesis in hairless mice. Proc Natl Acad Sci USA 101:
3933–3938, 2004
Hastak K, Agarwal MK, Mukhtar H, Agarwal ML: Ablation of either p21 or Bax
prevents p53-dependent apoptosis induced by green tea polyphenol
epigallocatechin-3-gallate. FASEB J 19:U344–U362, 2005
Hill-Kapturczak N, Thamilselvan V, Liu FY, Nick HS, Agarwal A: Mechanism of
heme oxygenase-1 gene induction by curcumin in human renal proximal
tubule cells. Am J Physiol-Renal Physiol 281:F851–F859, 2001
ACTIVATION OF MOLECULAR ADAPTATION TO SUNLIGHT xix125 : 5 NOVEMBER 2005
